IONS MT Newswires 2 days ago Ionis Pharmaceuticals Insider Sold Shares Worth $323,490, According to a Recent SEC Filing ➖ AI Sentiment Neutral 5/10
IONS MT Newswires 4 days ago Ionis, Otsuka Receive European Commission Approval for Hereditary Angioedema Treatment Dawnzera
IONS Business Wire 4 days ago DAWNZERA™ (donidalorsen) approved in the European Union for hereditary angioedema (HAE)